Which combination is commonly used as supportive evidence for FIP before histopathology?

• A. Rivalta test on effusion and coronavirus PCR
• B. Chest radiography and blood pressure measurement
• C. Urinalysis and fecal culture
• D. Serum amyloid A and liver enzymes

Answer: (A)

Evaluating suspected FIP before histopathology relies on practical, non-invasive clues that together raise or lower suspicion. The most useful combination is performing the Rivalta test on the effusion and testing the effusion fluid for coronavirus RNA with PCR.

The Rivalta test is a simple qualitative assay for effusions; a positive result suggests an inflammatory, protein-rich, exudative effusion typical of FIP, though it isn’t perfectly specific on its own. Pairing that with coronavirus PCR on the same effusion detects FCoV RNA in the fluid. While FCoV presence isn’t exclusive to FIP, finding both a positive Rivalta result and FCoV RNA in the effusion strongly supports FIP in the right clinical context, making it a common, practical prehistology clue.

The other options don’t provide a targeted, condition-specific supportive signal. Chest radiography and blood pressure can be helpful pieces of the overall picture but aren’t as indicative for FIP specifically. Urinalysis with fecal culture is not particularly relevant to FIP, and serum amyloid A with liver enzymes are nonspecific inflammatory markers that don’t offer the same diagnostic value before histopathology.